UK

UK gets early access to Roche’s breast cancer immunotherapy
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Flag link:
Pharma urges politicians to stop no-deal Brexit in today’s vote
Pharma urges politicians to stop no-deal Brexit in today’s vote
Pharmaforum
Brexit
UK
Europe
Flag link:
Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff
Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff
Fierce Pharma
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
NHS
UK
Orkambi
Flag link:
It's not a Brexit problem, Sanofi says of epilepsy drug shortages
It's not a Brexit problem, Sanofi says of epilepsy drug shortages
Fierce Pharma
Sanofi
drug shortages
Brexit
UK
epilepsy
Epilim
Depakote
Flag link:
Brexit could disrupt medicine supplies for six months – minister
Brexit could disrupt medicine supplies for six months – minister
Pharmaforum
Brexit
UK
Europe
Flag link:
Biotech in post-Brexit Britain: the future for the UK’s pharma-innovation engine?
Biotech in post-Brexit Britain: the future for the UK’s pharma-innovation engine?
Pharmaforum
drug development
UK
Brexit
innovation
Flag link:
Brexit Likely to Cause Talent Shortage for Biopharma in the UK
Brexit Likely to Cause Talent Shortage for Biopharma in the UK
BioSpace
UK
Europe
Brexit
Flag link:
U.K. Could Be Kicked Out Of Newly Launched Pharma Tech Security System Because Of Brexit
U.K. Could Be Kicked Out Of Newly Launched Pharma Tech Security System Because Of Brexit
Forbes
Europe
UK
Brexit
Falsified Medicines Directive
security
Flag link:
Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company
Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company
Fierce Pharma
Novartis
Kymriah
CAR-T
UK
diffuse large B-cell lymphoma
Gilead Sciences
Flag link:
Brexit could hinder CAR-T reimbursement in Europe
Brexit could hinder CAR-T reimbursement in Europe
Pharmaforum
Brexit
UK
Europe
CAR-T
Flag link:
Biopharma Companies Explain Brexit Preparations
Biopharma Companies Explain Brexit Preparations
RAPS.org
Brexit
UK
Europe
drug shortages
Flag link:
Novartis urges Britain to secure drug supplies before Brexit
Novartis urges Britain to secure drug supplies before Brexit
Yahoo/Reuters
Novartis
UK
Brexit
Europe
drug shortages
Flag link:
Brexit and beyond: the challenges ahead for pharma
Brexit and beyond: the challenges ahead for pharma
Pharmaforum
Brexit
UK
Europe
Flag link:
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
Fierce Biotech
EMA
Europe
Brexit
UK
Amsterdam
Flag link:
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
NICE
UK
Amgen
Novartis
migraines
Aimovig
Flag link:
Pharma companies warned over ‘no deal’ Brexit disruption
Pharma companies warned over ‘no deal’ Brexit disruption
Pharmaforum
UK
Brexit
Flag link:
The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
Endpoints
pharma industry
UK
Europe
Brexit
Flag link:
Survey Indicates Healthcare Professionals Have a Dim View of Post-Brexit Britain
Survey Indicates Healthcare Professionals Have a Dim View of Post-Brexit Britain
BioSpace
UK
Brexit
Flag link:
British genetic database expects $320 million investment
British genetic database expects $320 million investment
San Francisco Chronicle
genetics
UK
genetic database
UK Biobank
Flag link:
Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London
Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London
Endpoints
Novartis
UK
Flag link:

Pages